Status: Recruiting
Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis
The OXYGEN-RCT trial is a randomized, controlled, double blinded, prospective, multi-center trial to demonstrate the safety and efficacy in adult benign central airway stenosis. Participates will be in a 1:1 allocation to treatment with the Airiver Pulmonary DCB or standard of care laryngoscopic/bronchoscopic balloon dilation, respectively.
Participants needed: 200
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Airiver Medical, Inc.Updated: Jun 18, 2026Locations: 1
Eligibility criteria
Age ≥ 22 years. [+9]
Two or more clinically significant (e.g. non-traversable) stenoses with total le...